Information
-
Trademark
-
98122765
-
International Classifications
-
Filing Date
August 08, 2023
a year ago
-
Transaction Date
November 08, 2024
2 months ago
-
Status Date
November 07, 2024
2 months ago
-
Published for Opposition Date
October 08, 2024
3 months ago
-
Location Date
October 21, 2024
3 months ago
-
First Use Anywhere Date
October 26, 2016
8 years ago
-
First Use In Commerce Date
October 26, 2016
8 years ago
-
Status Code
774
-
Current Location
PETITIONS OFFICE
Employee Name
DONEGAN, DANIEL
-
Attorney Docket Number
291900
Attorney Name
MICHELLE L. ZIMMERMANN
Law Office Assigned Location Code
L40
-
Owners
Mark Drawing Code
4
Mark Identification
VYRIAD
Case File Statements
- GS0051: Pharmaceuticals, namely, bio-pharmaceuticals for the treatment of cancer; stem cells for medical use for the treatment of cancer,
cardiovascular diseases, and heritable genetic diseases; medicinal preparations for use in oncology; pharmaceutical preparations
for the treatment of immune system related diseases and disorders, namely, cancer and cardiovascular diseases and heritable
genetic diseases; pharmaceutical preparations for treatment of genetic and heritable genetic diseases; cellular pharmaceutical
preparations for use in oncology and cardio-vascular diseases; living tissue in the nature of chimeric antigen receptor (CAR-T)
cells for medical use for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; pharmaceutical
preparations for use in oncology; all of the foregoing to exclude infectious diseases
- GS0421: Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; research and
development of bio-pharmaceuticals for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; medical
and scientific research in the fields of genetics and oncology; research and development of technology in the fields of stem cells
and stem cell therapy for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; development of
genetic therapies and chimeric antigen receptor cell (CAR-T) cell therapies for the treatment of cancer, cardiovascular diseases,
and heritable genetic diseases; scientific research and development of cell therapies, namely, chimeric antigen receptor T-cells
(CAR-T) to cure solid tumor cancers and other cancers; medical and scientific research services in the fields of genetics, cell
therapy, oncology, immuno-oncology; all of the foregoing to exclude infectious diseases
Case File Event Statements
-
8/11/2023 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
9/8/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
4/8/2024 - 10 months ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
4/10/2024 - 9 months ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/10/2024 - 9 months ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
4/10/2024 - 9 months ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/14/2024 - 7 months ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/14/2024 - 7 months ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/14/2024 - 7 months ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/5/2024 - 5 months ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
9/18/2024 - 4 months ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
10/3/2024 - 4 months ago
12 - TEAS POST PUBLICATION AMENDMENT RECEIVED
Type: EPPA
-
10/8/2024 - 3 months ago
13 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
10/8/2024 - 3 months ago
14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
10/21/2024 - 3 months ago
15 - ASSIGNED TO PETITION STAFF
Type: APET
-
11/4/2024 - 3 months ago
16 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Type: CHPB
-
11/7/2024 - 2 months ago
17 - OPPOSITION PAPERS RECEIVED AT TTAB
Type: OPPF
-
11/7/2024 - 2 months ago
18 - OPPOSITION INSTITUTED NO. 999999
Type: OP.I
